Daniel D. Waller

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 348 citations · Full text

Hematological Malignancy, Proteasome Inhibitors, Relapsed Myeloma +10

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma

Phyllis S.Y. Chong, Jianbiao Zhou, Julia S.L. Lim et al. · Cancer Research · 2019 · 77 citations · Full text

Shp2 Repression, Hematological Malignancy, Transcriptional Regulation +15

Unraveling the Prenylation–Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors

Cyrus M. Lacbay, Daniel D. Waller, Jaeok Park et al. · Journal of Medicinal Chemistry · 2018 · 43 citations · Full text

Hematological Malignancy, Prenylation–cancer Paradox, Oncology +15

Nup53p is a Target of Two Mitotic Kinases, Cdk1p and Hrr25p

C. Patrick Lusk, Daniel D. Waller, Taras Makhnevych et al. · Traffic · 2007 · 40 citations · Full text

Rho5p Is Involved in Mediating the Osmotic Stress Response in <i>Saccharomyces cerevisiae</i> , and Its Activity Is Regulated via Msi1p and Npr1p by Phosphorylation and Ubiquitination

Robert B. Annan, Cunle Wu, Daniel D. Waller et al. · Eukaryotic Cell · 2008 · 31 citations · Full text

Molecular Regulation, Molecular Biology, Cellular Physiology +23